Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $20.61 USD
Change Today -1.20 / -5.50%
Volume 248.2K
ADRO On Other Exchanges
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Stephen T. Isaacs

Chairman, Chief Executive Officer and President,Aduro BioTech, Inc.
AgeTotal Calculated CompensationThis person is connected to 11 board members in 1 different organizations across 2 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Stephen T. Isaacs has been Chairman, Chief Executive Officer and President of Aduro BioTech, Inc. since 2008. Mr. Isaacs was the founder of Cerus Corporation and served as its President and Chief Executive Officer from September 1991 to May 10, 2004. While at Cerus, he led financings and partnerships providing over $250 million and negotiated major contracts with Baxter Healthcare Inc., the Consortium for Plasma Science, Kirin Pharmaceuticals and the Medimmune Corporation. ...

Read Full Background

Corporate Headquarters*

626 Bancroft Way
Berkeley, California 94710

United States

Phone: 510-848-4400
Fax: --

Board Members Memberships*

Chairman, Chief Executive Officer and President


Bachelor's Degree 1973
University of California Berkeley

Other Affiliations*

Annual Compensation*

Total Annual Compensation$886,600

Stock Options*

All Other Compensation$6,146
Exercisable Options1,989,859
Unexercisable Options1,172,786
Total Number of Options3,162,645

Total Compensation*

Total Annual Cash Compensation$892,746
Total Short Term Compensation$886,600
Other Long Term Compensation$6,146
Total Calculated Compensation$1,502,126
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ADRO:US $20.61 USD -1.20


J. Joseph Kim Ph.D.Chief Executive Officer, President, Director and Member of Finance Committee
Inovio Pharmaceuticals, Inc.
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
Anthony S. Marucci M.B.A.Founder, Chief Executive Officer, President and Director
Celldex Therapeutics, Inc.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ADURO BIOTECH INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at